alfuzosin has been researched along with Urinary Bladder, Overactive in 4 studies
alfuzosin: structure given in first source
Urinary Bladder, Overactive: Symptom of overactive detrusor muscle of the URINARY BLADDER that contracts with abnormally high frequency and urgency. Overactive bladder is characterized by the frequent feeling of needing to urinate during the day, during the night, or both. URINARY INCONTINENCE may or may not be present.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy and safety of treatment with alfuzosin 10 mg plus propiverine 10 or 20 mg in men with lower urinary tract symptoms (LUTS) and an overactive bladder were investigated." | 9.19 | Comparison of alfuzosin 10 mg with or without propiverine 10 mg, 20 mg in men with lower urinary tract symptom and an overactive bladder: randomised, single-blind, prospective study. ( Cho, HJ; Cho, JM; Kang, JY; Moon, HS; Seo, DY; Shin, SC; Sung, LH; Yoo, TK; Yu, JH, 2014) |
| "The efficacy and safety of treatment with alfuzosin 10 mg plus propiverine 10 or 20 mg in men with lower urinary tract symptoms (LUTS) and an overactive bladder were investigated." | 5.19 | Comparison of alfuzosin 10 mg with or without propiverine 10 mg, 20 mg in men with lower urinary tract symptom and an overactive bladder: randomised, single-blind, prospective study. ( Cho, HJ; Cho, JM; Kang, JY; Moon, HS; Seo, DY; Shin, SC; Sung, LH; Yoo, TK; Yu, JH, 2014) |
| "Alfuzosin has α1-adrenoreceptor antagonist activity and is available worldwide for the treatment of lower urinary tract symptoms resulting from benign prostate hyperplasia." | 2.48 | Alfuzosin for the treatment of storage symptoms suggestive of overactive bladder. ( Cho, KJ; Kim, JC, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, HJ | 1 |
| Shin, SC | 1 |
| Seo, DY | 1 |
| Cho, JM | 1 |
| Kang, JY | 1 |
| Yoo, TK | 1 |
| Yu, JH | 1 |
| Sung, LH | 1 |
| Moon, HS | 1 |
| Cho, KJ | 1 |
| Kim, JC | 1 |
| Sinha, D | 1 |
| Arunkalaivanan, A | 1 |
| Geppetti, P | 1 |
| Nassini, R | 1 |
| Materazzi, S | 1 |
| Benemei, S | 1 |
2 reviews available for alfuzosin and Urinary Bladder, Overactive
| Article | Year |
|---|---|
Alfuzosin for the treatment of storage symptoms suggestive of overactive bladder.
Topics: Adrenergic alpha-Antagonists; Animals; Humans; Quinazolines; Urinary Bladder, Overactive | 2012 |
The concept of neurogenic inflammation.
Topics: Adrenergic alpha-Antagonists; Animals; Calcium Channels; Humans; Male; Nerve Tissue Proteins; Neurog | 2008 |
1 trial available for alfuzosin and Urinary Bladder, Overactive
| Article | Year |
|---|---|
Comparison of alfuzosin 10 mg with or without propiverine 10 mg, 20 mg in men with lower urinary tract symptom and an overactive bladder: randomised, single-blind, prospective study.
Topics: Benzilates; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Pros | 2014 |
1 other study available for alfuzosin and Urinary Bladder, Overactive
| Article | Year |
|---|---|
Urethral syndrome: response to alpha-adrenergic blocking agents.
Topics: Adrenergic alpha-Antagonists; Adult; Depression; Female; Humans; Quinazolines; Remission Induction; | 2006 |